Adherence to GDMT for heart failure is suboptimal. GDMT for HFrEF includes an ACEi/ARB/ARNI, beta-blocker/ivabradine, and MRA. The “polypill” is a fixed-dose combination of medications for the prevention of CVD. The SCCS Polypill Pilot trial showed adherence to a polypill regimen is high (86% at 12 months). Additionally, the polypill led to greater reductions in SBP and LDL levels compared to the usual-care group in persons with low socioeconomic status.
Does the polypill have a role in improving adherence rates to GDMT in patients with HFrEF? What other strategies are under development for improving adherence rates?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.